Glycoengineering is increasingly recognized as an important strategy in the development of new biopharmaceuticals with optimized half-life, antigenicity, and efficacy. With years of experience and advanced technologies, Creative Biolabs has proposed different genetic strategies to circumvent issues like heterogeneity, nonhuman glycans in different glycoprotein production systems. Learn more, https://www.creative-biola...

Only people mentioned by cailynn in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from cailynn johnson, click on at the bottom under it